Avanir To Pay $108M Over Nuedexta Drug Kickback Scheme
Drugmaker Avanir Pharmaceuticals has agreed to shell out more than $108 million in criminal penalties, forfeiture and civil damages for an alleged kickback scheme that involved the company paying physicians to...To view the full article, register now.
Already a subscriber? Click here to view full article